Cancer related death News

A group of researchers discovered a novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer. Research led by Barts Cancer Institute (BCI) at Queen Mary University of London, the Italian Institute for Genomic Medicine, and the University of Milan. The findings were published in the journal Cell Reports, revealing how the gene influences the generation of genetic variants in prostate cancer that may predict disease relapse and represent new drug targets to improve patient survival.